Curis Lifesciences IPO
Curis Lifesciences IPO
Overview
Curis Lifesciences IPO is a book build issue of ₹27.52 crores. The issue is entirely a fresh issue of 0.22 crore shares of ₹27.52 crore. Curis Lifesciences IPO opens for subscription on Nov 7, 2025 and closes on Nov 11, 2025. The allotment for the Curis Lifesciences IPO is expected to be finalized on Nov 12, 2025. Curis Lifesciences IPO will list on NSE SME with a tentative listing date fixed as Nov 14, 2025. Curis Lifesciences IPO price band is set at ₹120.00 to ₹128.00 per share . The lot size for an application is 1,000. The minimum amount of investment required by an individual investor (retail) is ₹2,56,000.00 (2,000 shares) (based on upper price). The minimum lot size investment for HNI is 3 lots (3,000 shares), amounting to ₹3,84,000. Finaax Capital Advisors Private Limited is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue. The Market Maker of the company is RS Wealth Management Private Limited.
Total Shares
21,50,000
Issue Size
₹27.52 Cr
Price Band
₹120 – ₹128
Lot Size
1000 shares
Min. Investment
₹2,56,000
Max. Investment
₹2,56,000
Open Date
07 Nov, 2025
Close Date
11 Nov, 2025
Allotment
12 Nov, 2025
Listing
14 Nov, 2025
Max. Investment
₹2,56,000
Announced
07 Nov, 2025
Opening Date
07 Nov, 2025
Closing Date
11 Nov, 2025
Basis of Allotment
12 Nov, 2025
Initiation of Refunds
13 Nov, 2025
Credit of Shares
13 Nov, 2025
Listing Date
14 Nov, 2025
Live GMP
Est. Listing: ₹134
Apply via UPI in 5 minutes
Choose your broker • Zero commission on IPO
About Curis Lifesciences IPO
Incorporated in 2010, Curis Lifesciences Limited is a pharmaceutical company that specializes in developing, manufacturing, and distributing a diverse range of products.
The company manufactures pharmaceutical products globally and domestically on a loan license or contract basis, as well as for its own brand marketing.
The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya.
Curis Lifesciences IPO Share Price
Issue Breakdown
Shareholding
Dilution: 36.2% increase in shares
Curis Lifesciences IPO Promoters Holding
Curis Lifesciences IPO Financial Health
Curis Lifesciences Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 25% between the financial year ending with March 31, 2025 and March 31, 2024.
Curis Lifesciences IPO Lot Size
Investors can bid for a minimum of 2,000 shares and in multiples of 1,000 shares thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2000 | ₹2,56,000 |
| Individual investors (Retail) (Max) | 2 | 2000 | ₹2,56,000 |
| S-HNI (Min) | 3 | 3000 | ₹3,84,000 |
| S-HNI (Max) | 7 | 7000 | ₹8,96,000 |
| B-HNI (Min) | 8 | 8000 | ₹10,24,000 |
(All values in CR)
Curis Lifesciences IPO Valuations
The market capitalization of Curis Lifesciences IPO is ₹103.48 Cr. KPI as of Mon, Mar 31, 2025.
| Metric | Value |
|---|---|
| ROE | 55.25 |
| ROCE | 27.83 |
| Debt/Equity | 0.96 |
| RoNW | 37.62 |
| PAT Margin | 12.43 |
| EBITDA Margin | 19.41 |
| Price to Book Value | 12.64 |
| Market Capitalization | 103.48 |
(All values in CR)
Curis Lifesciences IPO Strength & Risk
Curis Lifesciences IPO Strength:
- Strong promoter and management team with deep experience in the pharmaceutical sector.
- Wide product portfolio including tablets, capsules, oral liquids, ointments, and ophthalmic products.
- WHO-GMP-certified manufacturing facility meeting international quality standards.
- Facility approved by global regulatory authorities, supporting export growth.
- Strategic plant location offering logistics and scalability advantages.
- Growing export presence with an expanding customer base in global markets.
- Demonstrated growth in revenue and profitability in recent periods.
- Focus on quality control, compliance, and innovation in formulation development.
Curis Lifesciences IPO Risk:
- Heavy dependence on a single manufacturing facility increases operational risk.
- Reliance on a limited number of major customers and suppliers.
- Volatility in raw material prices may impact profit margins.
- Exposure to foreign exchange fluctuations due to export dependence.
- Operating in a highly regulated sector with stringent compliance requirements.
- Any delay in product approvals can affect growth and operations.
- Competition from established domestic and global pharmaceutical companies.
- Disruption in supply chain or logistics may impact timely deliveries.
Curis Lifesciences IPO Subscriptions Status
Curis Lifesciences IPO subscribed 74.39 times. The public issue subscribed 44.28 times in the individual investors category, 96.17 times in QIB (Ex Anchor), and 115.46 times in the NII category by November 11, 2025 6:19:59 PM (Day 3).
| Investor Category | Subscription (times) | Shares Offered | Shares bid for | Total Amount (Rs Cr.) |
|---|---|---|---|---|
| Anchor | 1.00 | 6,09,000 | 6,09,000 | 7.8 |
| Market Maker | 1.00 | 1,08,000 | 1,08,000 | 1.38 |
| QIB (Ex Anchor) | 96.17 | 4,09,000 | 3,93,35,000 | 503.49 |
| Non-Institutional Buyers | 115.46 | 3,08,000 | 3,55,63,000 | 455.21 |
| bNII (bids above ₹10L) | 142.74 | 2,06,000 | 2,94,04,000 | 376.37 |
| sNII (bids below ₹10L) | 60.38 | 1,02,000 | 61,59,000 | 78.84 |
| Individual Investors (IND category bidding for 2 Lots) | 44.28 | 7,16,000 | 3,17,06,000 | 405.84 |
| Total | 74.39 | 14,33,000 | 10,66,04,000 | 1 |
Curis Lifesciences IPO GMP
Curis Lifesciences SME IPO last GMP is ₹6, last updated Nov 11th 2025 05:28 PM. With the price band of 128.00, Curis Lifesciences SME IPO's estimated listing price is ₹134 (cap price + today's GMP).The expected percentage gain/loss per share is 4.69%. >> Curis Lifesciences SME IPO Retail Subject to Sauda: ₹4600 The lowest GMP is ₹0.00, while the highest GMP is ₹8.00.
Last updated 11 Nov, 2025 · Source: aggregated grey-market dealers
| Date | IPO Price | GMP | Sub2 Sauda | Est. Listing | Est. Profit | Updated |
|---|---|---|---|---|---|---|
| 11 Nov, 2025 | 128 | ₹6▼ | 4600 | ₹134 (4.69%) | 6000 | 11 Nov, 2025 |
| 10 Nov, 2025 | 128 | ₹8 | 6100 | ₹136 (6.25%) | 8000 | 10 Nov, 2025 |
| 09 Nov, 2025 | 128 | ₹8 | 6100 | ₹136 (6.25%) | 8000 | 09 Nov, 2025 |
| 08 Nov, 2025 | 128 | ₹8▲ | 6100 | ₹136 (6.25%) | 8000 | 08 Nov, 2025 |
| 07 Nov, 2025 | 128 | ₹7.5 | 5700 | ₹135.5 (5.86%) | 7500 | 07 Nov, 2025 |
| 06 Nov, 2025 | 128 | ₹7.5▲ | 5700 | ₹135.5 (5.86%) | 7500 | 06 Nov, 2025 |
| 05 Nov, 2025 | 128 | ₹6▲ | 4600 | ₹134 (4.69%) | 6000 | 05 Nov, 2025 |
| 04 Nov, 2025 | 128 | ₹0 | - | ₹128 (0.00%) | - | 04 Nov, 2025 |
| 03 Nov, 2025 | 128 | ₹0 | - | ₹128 (0.00%) | - | 03 Nov, 2025 |
| 01 Nov, 2025 | 128 | ₹0 | - | ₹128 (0.00%) | - | 01 Nov, 2025 |
| 31 Oct, 2025 | 128 | ₹0 | - | ₹ (%) | - | 31 Oct, 2025 |
Disclaimer: GMP is an unofficial signal from grey-market dealers and is not regulated by SEBI. Use it alongside subscription data and other research for informed decision-making.
How to Apply for Curis Lifesciences IPO
Login to Your Trading App
Open Zerodha, Upstox, Groww, Angel One, or any brokerage app.
Go to IPO Section
Find Curis Lifesciences IPO under the IPO section. Select it and enter your bid details — choose lot size and price (cut-off price recommended).
Enter UPI ID and Submit
Provide your UPI ID linked to your bank account and submit the application.
Approve Mandate on UPI App
Open your UPI app (Google Pay, PhonePe, Paytm, BHIM) and approve the IPO payment request.
Application Confirmed
Your funds will be blocked in your account until the IPO allotment process is completed.